LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma

Lysyl oxidase‐like 2 (LOXL2) has shown to promote metastasis and poor prognosis in hepatocellular carcinoma (HCC). Also, we have previously reported that vasculogenic mimicry (VM) is associated with invasion, metastasis and poor survival in HCC patients. In the present study, we investigated molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Bing, Zhao, Xiulan, Liu, Tieju, Zhang, Yanhui, Sun, Ran, Dong, Xueyi, Liu, Fang, Zhao, Nan, Zhang, Danfang, Wu, Lili, Wang, Yong, Wang, Meili, Meng, Jie, Lin, Xian, Sun, Baocun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349148/
https://www.ncbi.nlm.nih.gov/pubmed/30506621
http://dx.doi.org/10.1111/jcmm.14039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349148/
https://www.ncbi.nlm.nih.gov/pubmed/30506621
http://dx.doi.org/10.1111/jcmm.14039

Ejemplares similares